跳到内容

肿瘤科(儿科)

血小板减少症的管理

Eltrombopag for secondary failure of platelet recovery post-allogeneic hematopoietic stem cell transplant in children. (打开新窗口)

Ali S, Gassas A, Kirby-Allen M, Krueger J, Ali M, Schechter T

来源‎: Pediatr Transplant 2017;21(6):e13017.

检索‎: PubMed 28653480

DOI码‎: 10.1111/petr.13017

https://www.ncbi.nlm.nih.gov/pubmed/28653480 (打开新窗口)

Romiplostim for immune thrombocytopenia in neuroblastoma patients receiving chemotherapy. (打开新窗口)

Fassel H, Bussel JB, Roberts SS, Modak S

来源‎: J Pediatr Hematol Oncol 2019;41(4):e257-9.

检索‎: PubMed 29683946

DOI码‎: 10.1097/MPH.0000000000001187

https://www.ncbi.nlm.nih.gov/pubmed/29683946 (打开新窗口)

Romiplostim for therapy-related thrombocytopenia in pediatric malignancies. (打开新窗口)

Jacobson AE, Shah N, Setty BA

来源‎: Pediatr Blood Cancer 2017;64(8):e26473.

检索‎: PubMed 28150377

DOI码‎: 10.1002/pbc.26473

http://www.ncbi.nlm.nih.gov/pubmed/28150377 (打开新窗口)

Eltrombopag for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation in children. (打开新窗口)

Li S, Wu R, Wang B, Fu L, Zhu G, Zhou X, Ma J, Zhang L, Qin M

来源‎: J Pediatr Hematol Oncol 2019;41(1):38-41.

检索‎: PubMed 30080752

DOI码‎: 10.1097/MPH.0000000000001263

https://www.ncbi.nlm.nih.gov/pubmed/30080752 (打开新窗口)

Romiplostim for secondary thrombocytopenia following allogeneic stem cell transplantation in children. (打开新窗口)

Maximova N, Zanon D, Rovere F, Maestro A, Schillani G, Paparazzo R

来源‎: Int J Hematol 2015;102(5):626-32.

检索‎: PubMed 26084627

DOI码‎: 10.1007/s12185-015-1821-1

https://www.ncbi.nlm.nih.gov/pubmed/26084627 (打开新窗口)

Chemotherapy induced thrombocytopenia in pediatric oncology. (打开新窗口)

Tamamyan G, Danielyan S, Lambert MP

来源‎: Crit Rev Oncol Hematol 2016;99:299-307.

检索‎: PubMed 26811139

DOI码‎: 10.1016/j.critrevonc.2016.01.005

https://www.ncbi.nlm.nih.gov/pubmed/26811139 (打开新窗口)

Oncological management of pediatric cancer patients belonging to Jehovahs Witnesses: a two-institutional experience report. (打开新窗口)

Tenenbaum T, Hasan C, Kramm CM, Janssen G, Laws HJ, Wessalowski R, Bode U, Göbel U

来源‎: Onkologie 2004;27(2):131-7.

检索‎: PubMed 15138344

DOI码‎: 10.1159/000076901

https://www.ncbi.nlm.nih.gov/pubmed/15138344 (打开新窗口)

Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience. (打开新窗口)

Tsimberidou AM, Giles FJ, Khouri I, Bueso-Ramos C, Pilat S, Thomas DA, Cortes J, Kurzrock R.

来源‎: Ann Oncol 2005;16(1):139-45.

检索‎: PubMed 15598951

DOI码‎: 10.1093/annonc/mdi007

https://www.ncbi.nlm.nih.gov/pubmed/15598951 (打开新窗口)

Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. (打开新窗口)

Wandt H, Frank M, Ehninger G, Schneider C, Brack N, Daoud A, Fackler-Schwalbe I, Fischer J, Gäckle R, Geer T, Harms P, Löffler B, Ohl S, Otremba B, Raab M, Schönrock-Nabulsi P, Strobel G, Winter R, Link H

来源‎: Blood 1998;91(10):3601-6.

检索‎: PubMed 9572994

https://www.ncbi.nlm.nih.gov/pubmed/9572994 (打开新窗口)